Home > Publications database > Comparative DNA Methylation Profiling of Human and Murine ALK ‐Positive B‐Cell Neoplasms > print

001     303357
005     20250806114414.0
024 7 _ |a 10.1002/gcc.70060
|2 doi
024 7 _ |a 1045-2257
|2 ISSN
024 7 _ |a 1098-2264
|2 ISSN
037 _ _ |a DKFZ-2025-01607
082 _ _ |a 610
100 1 _ |a Glaser, Selina
|0 0009-0008-2923-1829
|b 0
245 _ _ |a Comparative DNA Methylation Profiling of Human and Murine ALK ‐Positive B‐Cell Neoplasms
260 _ _ |a New York, NY
|c 2025
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1754389603_9137
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a Division Adaptive Immunity and Lymphoma, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de
700 1 _ |a Wagener, Rabea
|b 1
700 1 _ |a Harkins, Shannon K.
|b 2
700 1 _ |a Voena, Claudia
|b 3
700 1 _ |a Bens, Susanne
|b 4
700 1 _ |a Klapper, Wolfram
|0 0000-0001-7208-4117
|b 5
700 1 _ |a Laurent, Camille
|b 6
700 1 _ |a Mathas, Stephan
|b 7
700 1 _ |a Ren, Meiqi
|0 P:(DE-He78)00559ea764f3549e2a9c714ecd8af73f
|b 8
700 1 _ |a Sander, Sandrine
|0 P:(DE-He78)3c4e3363a68498c72ad042b849e11f3a
|b 9
|u dkfz
700 1 _ |a Schnaudt-Mastrangelo, Charlotte
|b 10
700 1 _ |a Wößmann, Wilhelm
|0 0000-0002-6315-0888
|b 11
700 1 _ |a Xerri, Luc
|b 12
700 1 _ |a Ammerpohl, Ole
|b 13
700 1 _ |a Zelenetz, Andrew D.
|b 14
700 1 _ |a Louissaint, Abner
|b 15
700 1 _ |a Chiarle, Roberto
|b 16
700 1 _ |a Siebert, Reiner
|b 17
773 _ _ |a 10.1002/gcc.70060
|g Vol. 64, no. 7, p. e70060
|0 PERI:(DE-600)1492641-6
|n 7
|p e70060
|t Genes, chromosomes & cancer
|v 64
|y 2025
|x 1045-2257
909 C O |o oai:inrepo02.dkfz.de:303357
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)00559ea764f3549e2a9c714ecd8af73f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)3c4e3363a68498c72ad042b849e11f3a
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2025
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2024-12-09
|w ger
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2024-12-09
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b GENE CHROMOSOME CANC : 2022
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-09
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-09
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2024-12-09
920 1 _ |0 I:(DE-He78)D180-20160331
|k D180
|l NWG Erworbene Immunität und Lymphome
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D180-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21